Need Support?
Master MassHealth ACOs/MCOs, Medicare, BCBS Massachusetts & 160+ Commercial Payer Requirements
Slash Claim Denials by 35% with CPT/HCPCS Code Precision
Navigate Massachusetts' Complex MassHealth Delivery System
Post Payments in 24-48 Hours—Zero Revenue Bottlenecks
Recover Outstanding A/R in 27 Days—46% Faster Than Industry Average
First-pass clean claim rates of 98%
Denial rates below 3%
Days in A/R reduced from 78+ days to under 21 days
Overall revenue improvement of 8-12%
Denials reduced by 35%
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs specializes in Massachusetts laboratory facilities, with deep expertise in MassHealth ACO/MCO requirements, BCBS policies, Medicare Administrative Contractor (MAC) Jurisdiction K (JK) requirements, and state-specific payer regulations. Our 98% first-pass clean claim rate and 99% client retention rate demonstrate our commitment to excellence.
The top five denial reasons are:
A Local Coverage Determination (LCD) is a Medicare policy that defines which tests are covered, which ICD-10 codes support medical necessity, and testing frequency limitations. Massachusetts falls under Medicare Administrative Contractor (MAC) Jurisdiction K (JK), administered by National Government Services, which has strict LCDs for molecular and genetic testing. Billing a test with a non-covered diagnosis code results in automatic denial and potential audit exposure.
We pre-verify medical necessity before testing, submit prior authorizations with comprehensive documentation to the appropriate MassHealth ACO/MCO or commercial payer, use LCD-compliant diagnosis coding, attach required medical records, and proactively communicate with payers to prevent denials. For denied claims, we submit detailed appeals with peer-reviewed literature and clinical guidelines. Our molecular/genetic testing claim acceptance rate is 98%.